Viral Infections
RSSArticles
-
January Is Cervical Cancer
Awareness MonthPap tests, HPV vaccines remain key prevention tools.
-
Remdesivir Injection and Baricitinib Tablets
Baricitinib/remdesivir should be used to treat suspected or laboratory-confirmed COVID-19 in hospitalized adults and pediatric patients ≥ age 2 years who require supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation.
-
USPSTF: Screen At-Risk Adolescents, Adults for Hepatitis B
Advocacy group says recommendations are too narrow.
-
Overcoming Vaccine Misinformation to Secure Staff Buy-In
Convincing staff a vaccine is important and safe will take a robust educational plan. Administrators can start by meeting with staff and encouraging them to ask questions. Leaders should emphasize the safety and efficacy data to dispel misinformation.
-
Rolling Out a COVID-19 Vaccine at Surgery Centers
Surgery center leaders should start educating staff about the vaccine candidates and create vaccine policies for employees and patients. Because vaccine demand is high, leaders also should prepare in case their facilities become designated vaccine administration sites.
-
Casirivimab + Imdevimab Injection
Casirivimab/imdevimab should be used to treat mild to moderate COVID-19 in adults and patients ≥ 12 years of age weighing at least 40 kg who have tested positive for SARS-CoV-2.
-
Even Moderate COVID-19 Cases Can Cause Serious Neurological Problems
Strokes, seizures, and movement disorders just a few complications observed.
-
Bamlanivimab Injection
Bamlanivimab is a neutralizing recombinant IgG1 monoclonal antibody that connects to the receptor-binding domain of the spike protein of SARS-CoV-2. The drug blocks attachment and entry of the virus into human cells.
-
FDA Issues Third COVID-19 Therapeutic EUA This Month
The list of COVID-19 therapeutics is growing rapidly.
-
AMA Prepares for COVID-19 Vaccine with Coding Updates
There are codes unique to two possible vaccines and other unique codes concerning administration of those vaccines.